• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

August 27, 2025

Restrictive transfusion hemoglobin (Hb) thresholds are currently recommended across multiple medical and surgical settings, but the optimal RBC transfusion threshold for patients with acute myocardial infarction (AMI) is unclear. Three of four randomized controlled trials with patients with AMI, including the Myocardial Ischemia and Transfusion (MINT) trial with 3504 participants, suggest that liberal transfusion hemoglobin thresholds may reduce mortality for patients with AMI. Based on a meta-analysis from four trials (n=4311), the AABB updated their guidelines. The AABB recommends a liberal RBC transfusion for hospitalized patients with AMI when hemoglobin falls below 10 g/dL (conditional recommendation, low-certainty evidence). A liberal transfusion strategy with a hemoglobin threshold of 10 g/dL resulted in 1.2% fewer deaths compared to a restrictive transfusion threshold of 7-8 g/dL. This new recommendation does not apply to patients without AMI. Future research should address optimal thresholds according to the type of myocardial infarction and other patient characteristics.

Reference:

Pagano MB, Stanworth SJ, Dennis J, Bakhtary S, et al. Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice Guidelines. Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-00706. Epub ahead of print. PMID: 40825204.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Transfusion Patients with Hereditary Hemorrhagic Telangiectasia Have Increased Risk of Alloimmunization

  • SARS-CoV-2 Seroprevalence in Blood Donors

  • Dithiothreitol (DTT)-based Method Validated for Blood Compatibility Testing in Patients Taking Daratumumab

Show Comments

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

  • Transfusion-related Alpha-Gal Syndrome

  • 2024 Serious Hazards of Transfusions (SHOT) Report in the U.K.

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley